Multiple Myeloma Clinical Trial

Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplantation

Summary

This clinical trial tests the feasibility, implementation and acceptability of chaplain delivered compassion meditation in order to improve spiritual care for patients receiving stem cell transplantation. Hospital chaplains play a vital role in delivering emotional and spiritual care to a broad range of both religious and non-religious patients for a wide variety of stressors, and extensive research indicates that spiritual consults impact patient outcomes and satisfaction. Compassion meditation is a secularized, research-based mindfulness and compassion meditation program designed to expand and strengthen compassion for self and others. Practices include training in attentional stability and increased emotional awareness, as well as targeted reflections to appreciate one's relationship with self and others. By centering the mind, controlling debilitating ruminative thoughts, and cultivating personal resiliency and an inclusive and more accurate understanding of others. Engaging in chaplain delivered compassion meditation may improve the spiritual care for patients receiving stem cell transplantation.

View Full Description

Full Description

PRIMARY OBJECTIVE:

I. To examine the feasibility, adoption, extent of implementation, acceptability and fidelity of chaplain-delivered compassion-centered spiritual health (CCSH).

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive chaplain-led compassionate centered spiritual health sessions over 30 minutes, twice per week for up to 2 weeks.

ARM II: Patients receive a traditional chaplain consultation and care upon request, per standard of care.

After completion of study treatment, patients are followed up at 80-100 days and 6 months post treatment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

PATIENT: Within 6 weeks of scheduled hematopoietic stem cell transplant (HSCT)
PATIENT: > 18 years of age
PATIENT: Speak and read English
CHAPLAIN: Emory Healthcare chaplain

Exclusion Criteria:

PATIENT: Patients will be excluded if they are cognitively impaired, on a ventilator, or are in a room requiring enteric precautions or airborne precautions (e.g., use of an N-95 mask requiring fit-testing) to enter
CHAPLAIN: There will be no exclusion criteria and no consequence to the chaplains for refusing to volunteer

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

50

Study ID:

NCT06328699

Recruitment Status:

Recruiting

Sponsor:

Emory University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Emory University Hospital/Winship Cancer Institute
Atlanta Georgia, 30322, United States More Info
Erin Brauer, MPH
Contact
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

50

Study ID:

NCT06328699

Recruitment Status:

Recruiting

Sponsor:


Emory University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.